Authors:
FORTNEY JT
GAN TJ
GRACZYK S
WETCHLER B
MELSON T
KHALIL S
MCKENZIE R
PARRILLO S
GLASS PSA
MOOTE C
WERMELING D
PARASURAMAN TV
DUNCAN B
CREED MR
AMOROSO M
BELO S
BOWIE MB
BUCKLEY N
CHENG E
CHUNG F
CLAYBORN L
CODA B
CONLAY L
COSMAN S
DUNCALF D
FANCIULLO G
FORTNEY J
FREID E
GRACZYK SG
GRAF G
GRATZ I
GREENBERG C
HALL R
HAYNES G
KALLAR S
KATARIA B
KHALIL S
KNOX D
KOEHNTOP DE
LEVY L
LUCAS S
LUI A
MALTBY R
MCKENZIE R
MELSON T
MIGUEL R
MOOTE C
OHARA D
PAVLIN J
RUNG G
SCUDERI P
SEBEL P
SEVERINO F
SOLANKI DR
STEINBERG R
SUNG YF
WEINGER M
WEIS FR
WERMELING D
WETCHLER B
WHITE P
WITKOWSKI TA
YU P
Citation: Jt. Fortney et al., A COMPARISON OF THE EFFICACY, SAFETY, AND PATIENT SATISFACTION OF ONDANSETRON VERSUS DROPERIDOL AS ANTIEMETICS FOR ELECTIVE OUTPATIENT SURGICAL-PROCEDURES, Anesthesia and analgesia, 86(4), 1998, pp. 731-738
Authors:
HOLDSWORTH MT
RAISCH DW
CHAVEZ CM
DUNCAN MH
PARASURAMAN TV
COX FM
Citation: Mt. Holdsworth et al., ECONOMIC-IMPACT WITH HOME DELIVERY OF CHEMOTHERAPY TO PEDIATRIC ONCOLOGY PATIENTS, The Annals of pharmacotherapy, 31(2), 1997, pp. 140-148
Authors:
GAN TJ
FORTNEY J
PARASURAMAN TV
CREED M
GRACZYK S
GLASS PSA
Citation: Tj. Gan et al., PATIENT SATISFACTION AND PHARMACOECONOMIC COMPARISON OF ONDANSETRON VS DROPERIDOL FOR THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN AMBULATORY SURGICAL PATIENTS, Anesthesiology, 87(3), 1997, pp. 53-53
Authors:
PATEL RI
DAVIS PJ
ORR RJ
FERRARI LR
RIMAR S
HANNALLAH RS
COHEN IT
COLINGO K
DONLON JV
HABERKERN CM
MCGOWAN FX
PRILLAMAN BA
PARASURAMAN TV
CREED MR
Citation: Ri. Patel et al., SINGLE-DOSE ONDANSETRON PREVENTS POSTOPERATIVE VOMITING IN PEDIATRIC OUTPATIENTS, Anesthesia and analgesia, 85(3), 1997, pp. 538-545
Citation: R. Thwaites et al., COST-EFFECTIVENESS OF 5-HYDROXYTRYPTAMINE(3) RECEPTOR ANTAGONISTS - ARETROSPECTIVE COMPARISON OF ONDANSETRON AND GRANISETRON, Anti-cancer drugs, 7(1), 1996, pp. 127-129
Authors:
CRUCITT MA
HYMAN W
GROTE T
TESTER W
MADAJEWICZ S
YEE S
WENTZ A
GRIFFIN D
PARASURAMAN TV
BRYSON J
Citation: Ma. Crucitt et al., EFFICACY AND TOLERABILITY OF ORAL ONDANSETRON VERSUS PROCHLORPERAZINEIN THE PREVENTION OF EMESIS ASSOCIATED WITH CYCLOPHOSPHAMIDE-BASED CHEMOTHERAPY AND MAINTENANCE OF HEALTH-RELATED QUALITY-OF-LIFE (VOL 18, PG 508, 1996), Clinical therapeutics, 18(4), 1996, pp. 778-788
Authors:
CRUCITT MA
HYMAN W
GROTE T
TESTER W
MADAJEWICZ S
YEE S
WENTZ A
GRIFFIN D
PARASURAMAN TV
BRYSON J
Citation: Ma. Crucitt et al., EFFICACY AND TOLERABILITY OF ORAL ONDANSETRON VERSUS PROCHLORPERAZINEIN THE PREVENTION OF EMESIS ASSOCIATED WITH CYCLOPHOSPHAMIDE-BASED CHEMOTHERAPY AND MAINTENANCE OF HEALTH-RELATED QUALITY-OF-LIFE, Clinical therapeutics, 18(3), 1996, pp. 508-518
Citation: Tv. Parasuraman et Jt. Osterhaus, COST-EFFECTIVENESS ANALYSIS OF ANTIEMETIC THERAPY FOR AMBULATORY SURGERY, Journal of clinical anesthesia, 7(5), 1995, pp. 440-441
Authors:
STEWART A
MCQUADE B
CRONJE JDE
GOEDHALS L
GUDGEON A
CORETTE L
FROGER X
TUBIANAHULIN M
LAPLAIGE P
ROBERTS JT
MCRAE J
FORSTER J
PARASURAMAN TV
BUTCHER M
Citation: A. Stewart et al., ONDANSETRON COMPARED WITH GRANISETRON IN THE PROPHYLAXIS OF CYCLOPHOSPHAMIDE-INDUCED EMESIS IN OUT-PATIENTS - A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMIZED, PARALLEL-GROUP STUDY, Oncology, 52(3), 1995, pp. 202-210
Authors:
PARASURAMAN TV
KIRCHDOERFER LJ
OSTERHAUS JT
Citation: Tv. Parasuraman et al., REEXAMINATION OF CLINICAL ASPECTS OF PHARMACOECONOMIC ANALYSIS, American journal of hospital pharmacy, 51(23), 1994, pp. 2971-2971